Aardvark Therapeutics

Forecast & Rating12 analysts currently cover Aardvark Therapeutics, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $11.11, about 107.7% upside from the current price of $5.35. Price targets range from $3.00 to $28.00 — a wide spread, showing clear disagreement over just how much Aardvark Therapeutics can rise. For you, this means institutional views on Aardvark Therapeutics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 24, 2026; for reference only and not investment advice.